°Áö¿µ1, °ÇöÈñ1, ¹ÚÂù±Ç1, ÀÌ»óÇÐ1, ¹®È½Ä1, À̼±¿µ2, ±èÈ£½Ä2
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ 1³»°úÇб³½Ç, 2»ýÈÇб³½Ç
Background: Recent research demonstrates a strong association between smoking-related behaviors and genetic
variation. We investigated the clinical features and genetic effects of dopamine receptors and a serotonin
transporter on smoking cessation in Koreans.
Methods: Smokers (n=51) wanting to quit smoking were included as the study population. They were genotyped
for polymorphisms in dopamine D2 receptor (DRD2) (TaqI and -141C), dopamine D4 receptor (DRD4),
and a serotonin transporter (5-HTT). We defined abstinence as stopping smoking at six months after
enrollment.
Results: Eighteen patients (35.3%) stopped smoking at six months. The abstinence group had a higher rate of
alcohol use whereas the non-abstinence group had more coughing. However, there were no significant differences
in average smoking rate, starting age of smoking, gender, nicotine dependence, and forced expiratory
volume in one second between the two groups. As for the genes in the dopamine pathway, the polymorphisms
of DRD2 TaqI (A1 allele) and DRD2 -141C (Ins C allele) were not genotypically different between the two
groups (P=0.245 and 0.409, respectively). The genetic variation in the DRD4 variable number of tandem repeats
(VNTR) also showed a similar distribution in the two groups. Regarding the polymorphisms of 5-HTT,
there was no difference in the long allele between the two groups (P=0.852).
Conclusions: This study suggests that the genetic variations of DRD2 TaqI, DRD2 -141C, DRD4 VNTR, and
5-HTT might have little influence on smoking cessation in Korean smokers.
Keywords: Genetic polymorphism, Smoking cessation, Dopamine receptor, Serotonin transporter |